The Centre for Commercialization of Regenerative Medicine (CCRM) is one of five new centres to be funded by the Government of Canada through the 2010 Centres of Excellence for the Commercialization of Research (CECR) competition. The CECR program is administered by the Networks of Centres of Excellence (NCE) Secretariat, which supports successful research partnerships between universities, industry, not-for-profit organizations and government.
The centre was awarded $15 million over five years, allowing its members to address the barriers faced by the Canadian regenerative medicine (RM) industry, such as the licensing of early-stage RM technologies to companies outside of Canada before their market value is realized.
Hosted by the University of Toronto, CCRM brings together leading RM experts from the University of Toronto and McMaster University, with researchers from the Hospital for Sick Children, the University Heath Network, the Ottawa Hospital Research Institute and Mount Sinai Hospital, to accelerate RM research and development, and create a commercialization pipeline that rapidly brings RM technologies to market. These researchers are working to harness the power of stem cells, biomaterials and molecules through innovative technologies to treat, and perhaps cure, diseased cells, tissues and organs.
To read the full, original article click on this link: PR-CANADA.net - Creating a Commercialization Pipeline for New Medical Technologies: Centre for Commercialization of
